Albert H. Kim, MD, PhD

Director of Brain Tumor Program
Surgical Director, Pituitary Center
Associate Professor of Neurological Surgery, Genetics, Neurology, and Developmental Biology
Co-Leader, Neurorestorative Therapy Group, Hope Center

Specialties

  • Meningiomas
  • Pituitary tumors
  • Vestibular schwannomas
  • Glioblastomas and other gliomas
  • Brain metastases
  • Chiari I malformation
  • Hydrocephalus

Call 314-362-3577 for Patient Appointments


We are absolutely committed to delivering the most innovative combination of surgery and science to each individual patient so that the best outcome is achieved.

Dr. Kim

Education

AB, East Asian Studies Harvard University Cambridge, MA
1990-1994

MA, Biology/Biomedical Science
Washington University School of Medicine St. Louis, MO
1995-1999

MD-PhD, New York University School of Medicine
New York, NY
1999-2003

Residency

Intern, Neurosurgery/General Surgery Brigham and Women’s Hospital
Boston, MA
2003-2004

Resident in Neurosurgery Brigham and Women’s Hospital
Boston, MA
2004-2010

Fellowship

Fellow, Neurosurgery Cerebrovascular and Skull Base
Jackson Memorial Hospital Miami, FL
2010-2011


Research focus

Brain tumors continue to be challenging and often devastating neurological diseases. My laboratory is interested in understanding the molecular mechanisms that drive tumor cell behavior in glioblastoma, a malignant brain cancer that is almost invariably fatal, as well as in aggressive forms of benign brain tumors, including meningiomas and pituitary tumors. Using my scientific training as a molecular neurobiologist and my experience as a board-certified brain tumor neurosurgeon, I have acquired expertise in generating model systems–patient-derived glioblastoma cell lines and CRISPR/Cas9-based tumor models in neural stem cells–for both mechanistic and translational studies. Our laboratory utilizes multidisciplinary approaches, from genetics and biochemistry to cell biology and preclinical in vivo brain tumor models, to discover new treatments for our patients.

View research, publications and collaborations »

Kim Lab

Identify the molecular signals that control normal brain development and the abnormal signals that drive brain tumors.


Honors & leadership roles

  • Phi Beta Kappa, Harvard University, 1994
  • Magna cum laude, Harvard University, 1994
  • Alpha Omega Alpha, New York University School of Medicine, 2002
  • Alpha Omega Alpha, New York University School of Medicine, 2013, 2017, 2019
  • Executive Committee, Southern Neurosurgical Society, 2016 – Present
  • Scientific Program Co-Chair, Society for Neuro-Oncology Annual Meeting Education Day, 2017
  • Scientific Program Co-Chair, Southern Neurosurgical Society Annual Meeting, 2018
  • Scientific Program Co-Chair, Tumor Section, Congress of Neurological Surgeons Annual Meeting, 2019
  •  Mentor Network Co-Chair, Southern Neurosurgical Society  2020 – Present       
  • Pre-Meeting Scientific Course Co-Chair, Society for Neuro-Oncology, 2020 – Present

Board certification

American Board of Neurological Surgeons (2015)


Hospital appointments

Barnes-Jewish Hospital